Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosavance 5600 in Postmenopausal Women With Osteoporosis
NCT00692913Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cholecalciferol in osteoporosis, Vitamin D deficiency (VDD), sponsored by Organon & Co.. Started Jun 2008; status: completed.
02
Drugs
cholecalciferol
03
Conditions
osteoporosisVitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT00692913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00692913.